{{Infobox drug
| drug_name = 替诺福韦二吡呋酯
| IUPAC_name = Bis{[(isopropoxycarbonyl)oxy]methyl} ({[(2''R'')-1-(6-amino-9''H''-purin-9-yl)-2-propanyl]oxy}methyl)phosphonate
| image = Tenofovir disoproxil structure.svg
| width = 260

<!--Clinical data-->
| tradename = 韦瑞德或其它
| synonyms = Tenofovir disoproxil fumerate
| Drugs.com = {{drugs.com|monograph|tenofovir-disoproxil-fumarate}}
| MedlinePlus = 
| pregnancy_AU = B3
| pregnancy_US = B
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = 口服（[[片剂|片剂]]）

<!-- Pharmacokinetic data -->
| bioavailability   = 25%
| protein_bound = 
| metabolism = 
| metabolites =
| onset = 
| elimination_half-life = 
| duration_of_action =
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 201341-05-1
| ATCvet = 
| ATC_prefix = J05
| ATC_suffix = AF07
| PubChem = 5481350
| DrugBank = 
| ChemSpiderID = 4587262
| UNII = F4YU4LON7I
| ChEBI = 63717
| NIAID_ChemDB = 080741

<!-- Chemical data -->
| C = 19 | H = 30 | N = 5 | O = 10 | P = 1
| molecular_weight  = 519.443 g/mol
| smiles = C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C
| StdInChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1
| StdInChIKey = JFVZFKDSXNQEJW-CQSZACIVSA-N
}}

{{Drugbox
| drug_name = 替诺福韦
| Watchedfields = changed
| verifiedrevid = 461742056
| IUPAC_name = ({[(2''R'')-1-(6-amino-9''H''-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid
| image = Tenofovir structure.svg
| width = 200

<!--Clinical data-->
| MedlinePlus = a602018
| routes_of_administration = [[口腔|口服]]

<!--Pharmacokinetic data-->
| protein_bound = < 1%
| elimination_half-life = 17小时
| excretion = [[肾脏|肾脏]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 147127-20-6
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 464205
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00300
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 408154
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 99YXE507IL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06074
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 483
| ChEBI = 63625
| synonyms = 9-(2-Phosphonyl-methoxypropyly)adenine (PMPA)

<!--Chemical data-->
| C=9 | H=14 | N=5 | O=4 | P=1
| molecular_weight = 287.213 g/mol
| smiles = O=P(O)(O)CO[C@H](C)Cn1c2ncnc(c2nc1)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SGOIRFVFHAKUTI-ZCFIWIBFSA-N
}}

<!-- Definition and uses -->
{{medical}}
'''替诺福韦二吡呋酯'''（{{lang-en|Tenofovir disoproxil}}），商品名'''韦瑞德'''（{{lang-en|Viread}}）或其它，是一种用于治疗慢性[[乙型肝炎|乙肝]]以及预防和治疗[[艾滋病|HIV感染/艾滋病]]的药物。<!-- <ref name=AHFS2016/> -->这种药物属于[[逆转录酶抑制剂|逆转录酶抑制剂]]，可以抑制HIV病毒的复制。<ref name=AHFS2016/>替诺福韦二吡呋酯可用于预防高危人群感染[[人類免疫缺陷病毒|HIV]]。<!-- <ref name=AHFS2016/> -->但药物不能治愈HIV/AIDS或乙肝。<ref name=AHFS2016/><ref>{{cite journal|last1=Martin|first1=P|last2=Lau|first2=DT|last3=Nguyen|first3=MH|last4=Janssen|first4=HL|last5=Dieterich|first5=DT|last6=Peters|first6=MG|last7=Jacobson|first7=IM|title=A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.|journal=Clinical Gastroenterology and Hepatology|date=November 2015|volume=13|issue=12|pages=2071–87.e16|pmid=26188135}}</ref>

药物呈片剂状或粉状，通常与其它抗病毒药物一起服用，<!-- <ref name=AHFS2016/> -->每日口服一次。<ref name=AHFS2016>{{cite web|title=Tenofovir Disoproxil Fumarate|url=https://www.drugs.com/monograph/tenofovir-disoproxil-fumarate.html|publisher=The American Society of Health-System Pharmacists|accessdate= 2016-11-29}}</ref>其常见副作用包括恶心、皮疹、腹泻、头痛、身体疼痛、抑郁症和虚弱等。<!-- <ref name=AHFS2016/> -->严重时可导致[[乳酸性酸中毒|乳酸性酸中毒]]和{{tsl|en|hepatomegaly|肝腫大}}。<!-- <ref name=AHFS2016/> -->在动物实验中未发现药物对[[妊娠|妊娠]]的影响。<!-- <ref name=AHFS2016/> -->

<!-- History and culture -->
替诺福韦于1996年申请专利，并于2001年在美国被批准使用。<ref>{{cite book|last1=Fischer|first1=Janos|last2=Ganellin|first2=C. Robin|title=Analogue-based Drug Discovery|date=2006|publisher=John Wiley & Sons|isbn=9783527607495|page=505|url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA505|language=en}}</ref>该药品是[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]药物之一，是目前医療制度中最有效和最安全的抗病毒药物之一。<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=2016-12-08|date=April 2015}}</ref>在美国，截至2015年，该药物仍无[[通用名药物|通用名版本]]，一個月費用超過200美元。<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=66}}</ref>在[[发展中国家|发展中国家]]，该药物的月批发成本则介于3.30到29.13美元之间。<ref>{{cite web|title=Tenofovir Disoproxil Fumerate (Tdf)|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=TENO300T&s_year=2014&year=2014&str=300%20mg&desc=Tenofovir%20Disoproxil%20Fumerate%20%28TDF%29&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E4%2E2%2E1&supplement=&class_name=%2806%2E4%2E2%2E1%29Nucleoside%2FNucleotide%20reverse%20transcriptase%20inhibitors%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=2016-11-30}}{{Dead link|date=2018年6月 |bot=InternetArchiveBot |fix-attempted=no }}</ref>

==参考来源==
{{reflist|32em}}

==外部链接==
* [http://www.viread.com/ 官方网站]

{{抗逆转录病毒药物}}
{{抗DNA病毒药物}}

[[Category:核苷类似物逆转录酶抑制剂|Category:核苷类似物逆转录酶抑制剂]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:嘌呤|Category:嘌呤]]
[[Category:前药|Category:前药]]
[[Category:杀微生物剂|Category:杀微生物剂]]